Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis US USD Issuing Entity by Quarter
US USD Issuing Entity — Novartis Capital Corporation (10 Bond Issues) ($M)
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | US USD Issuing Entity — Novartis Capital Corporation (10 Bond Issues) ($M) | Year on year | Source |
|---|
Breakdown
What makes up US USD Issuing Entity
- USD 1250M Bond (2.000%, 2020–2027)–
- USD 1500M Bond (2.200%, 2020–2030)–
- USD 1250M Bond (2.750%, 2020–2050)–
- USD 1000M Bond (3.100%, 2017–2027)–
- USD 500M Bond (3.7%, 2012–2042)–
- USD 1000M Bond (3.800%, 2024–2029)–
- USD 850M Bond (4.000%, 2024–2031)–
- USD 1250M Bond (4.0%, 2015–2045)–
- USD 1100M Bond (4.200%, 2024–2034)–
- USD 1850M Bond (4.4%, 2014–2044)–
- USD 750M Bond (4.700%, 2024–2054)–
Cite this data
StockData. (2026). Novartis US USD Issuing Entity ($M), quarterly [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/sub-issuer-ncc-us
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.